Insulin receptor isoforms are differently expressed during human osteoblastogenesis

Differentiation

Volumn 83, Issue 5, 2012, Pages 242-248

  Avnet, Sofia ^a   Perut, Francesca ^a   Salerno, Manuela ^a   Sciacca, Laura ^b   Baldini, Nicola ^a,c  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Differentiation; Human; Insulin receptor isoforms; Mesenchimal stromal cells; Osteoblasts

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; INSULIN RECEPTOR; INSULIN RECEPTOR A; INSULIN RECEPTOR B; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALKALINE PHOSPHATASE; ANTIGENS, CD; BONE AND BONES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; PROTEIN ISOFORMS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TRANSFECTION;

ANIMALIA;

EID: 84859073430     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2012.02.002     Document Type: Article

References (35)

1. Avnet S., Sciacca L., Salerno M., Gancitano G., Cassarino M.F., Longhi A., Zakikhani M., Carboni J.M., Gottardis M., Giunti A., Pollak M., Vigneri R., Baldini N. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Research 2009, 69:2443-2452.
2. Belfiore A. The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Current Pharmaceutical Design 2007, 13:671-686.
3. Belfiore A., Frasca F., Pandini G., Sciacca L., Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocrine Reviews 2009, 30:586-623.
4. Berman S.D., Calo E., Landman A.S., Danielian P.S., Miller E.S., West J.C., Fonhoue B.D., Caron A., Bronson R., Bouxsein M.L., Mukherjee S., Lees J.A. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:11851-11856.
5. Cenni E., Perut F., Ciapetti G., Savarino L., Dallari D., Cenacchi A., Stagni C., Giunti A., Fornasari P.M., Baldini N. In vitro evaluation of freeze-dried bone allografts combined with platelet rich plasma and human bone marrow stromal cells for tissue engineering. Journal of Materials Science Materials in Medicine 2009, 20:45-50.
6. Conover C.A. The role of insulin-like growth factors and binding proteins in bone cell biology. Principles of bone biology 1996, 607-618. Academic Press, New York, NY. J. Bilezikian, L.G. Lawrence, A.R. Gideon (Eds.).
7. Entingh A.J., Taniguchi C.M., Kahn C.R. Bidirectional regulation of brown fat adipogenesis by the insulin receptor. The Journal of Biological Chemistry 2003, 278:33377-33383.
8. Epstein S., LeRoith D. Diabetes and fragility fractures-a burgeoning epidemic?. Bone 2008, 43:3-6.
9. Ferron M., Wei J., Yoshizawa T., Del Fattore A., DePinho R.A., Teti A., Ducy P., Karsenty G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010, 142:296-308.
10. Frasca F., Pandini G., Scalia P., Mineo R., Costantino A., Goldfine I.D., Belfiore A., Vigneri R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Molecular and Cellular Biology 1999, 19:3278-3288.
11. Fulzele K., DiGirolamo D.J., Liu Z., Xu J., Messina J.L., Clemens T.L. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. The Journal of Biological Chemistry 2007, 282:25649-25658.
12. Granchi D., Ochoa G., Leonardi E., Devescovi V., Baglìo S.R., Osaba L., Baldini N., Ciapetti G. Gene expression patterns related to osteogenic differentiation of bone marrow-derived mesenchymal stem cells during ex vivo expansion. Tissue Engineering Part C, Methods 2010, 16:511-524.
13. Guarino V., Causa F., Taddei P., Di Foggia M., Ciapetti G., Martini D., Fagnano C., Baldini N., Ambrosio L. Polylactic acid fibre-reinforced polycaprolactone scaffolds for bone tissue engineering. Biomaterials 2008, 29:3662-3670.
14. Hofbauer L.C., Brueck C.C., Singh S.K., Dobnig H. Osteoporosis in patients with diabetes mellitus. Journal of Bone and Mineral Research 2007, 22:1317-1328.
15. Kassi E., Papavassiliou A.G. A possible role of osteocalcin in the regulation of insulin secretion: human in vivo evidence?. The Journal of Endocrinology 2008, 199:151-153.
16. Kellerer M., Lammers R., Ermel B., Tippmer S., Vogt B., Obermaier-Kusser B., Ullrich A., Häring H.U. Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities. Biochemistry 1992, 31:4588-4596.
17. Kulterer B., Friedl G., Jandrositz A., Sanchez-Cabo F., Prokesch A., Paar C., Scheideler M., Windhager R., Preisegger K.H., Trajanoski Z. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 2007, 8:70-84.
18. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., Dacquin R., Mee P.J., McKee M.D., Jung D.Y., Zhang Z., Kim J.K., Mauvais-Jarvis F., Ducy P., Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
19. LeRoith D., Yakar S. Mechanism of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nature Clinical Practice Endocrinology & Metabolism 2007, 3:302-310.
20. Malaguarnera R., Frasca F., Garozzo A., Gianì F., Pandini G., Vella V., Vigneri R., Belfiore A. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. The Journal of Clinical Endocrinology and Metabolism 2011, 96:766-774.
21. Maor G., Karnieli E. The insulin-sensitive glucose transporter (GLUT4) is involved in early bone growth in control and diabetic mice, but is regulated through the insulin-like growth factor I receptor. Endocrinology 1990, 140:1841-1851.
22. Martin T.J. A skeleton key to metabolism. Nature Medicine 2007, 13:1021-1023.
23. Martineau-Doize B., McKee M.D., Warshawsky H., Bergeron J.J. In vivo demonstration by radioautography of binding sites for insulin in liver kidney and calcified tissues of the rat. The Anatomical Record 1986, 214:130-140.
24. Middleton J., Arnott N., Walsh S., Beresford J. Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. Bone 1995, 16:287-293.
25. Moller D.E., Yokota A., Caro J.F., Flier J.S. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Molecular Endocrinology 1989, 3:1263-1269.
26. Mosthaf L., Grako K., Dull T.J., Coussens L., Ullrich A., McClain D.A. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. The EMBO Journal 1990, 9:2409-2413.
27. Pandini G., Vigneri R., Costantino A., Frasca F., Ippolito A., Fujita-Yamaguchi Y., Siddle K., Goldfine I.D., Belfiore A. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clinical Cancer Research 1999, 5:1935-1944.
28. Schwartz A.V. Diabetes mellitus: does it affect bone?. Calcified Tissue International 2003, 73:515-519.
29. Sciacca L., Prisco M., Wu A., Belfiore A., Vigneri R., Baserga R. Signaling differences from the A and B isoforms of the insulin receptor (INSR) in 32D cells in the presence or absence of INSR substrate-1. Endocrinology 2003, 44:2650-2658.
30. Serrano R., Villar M., Martínez C., Carrascosa J.M., Gallardo N., Andrés A. Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue. Journal of Molecular Endocrinology 2005, 24:153-161.
31. Slaaby R., Schäffer L., Lautrup-Larsen I., Andersen A.S., Shaw A.C., Mathiasen I.S., Brandt J. Hybrid receptors formed by insulin receptor (IR) and insulinlike growth factor I receptor (IGF1R) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. The Journal of Biological Chemistry 2006, 281:25869-25874.
32. Thomas D.M., Hards D.K., Rogers S.D., Ng K.W., Best J.D. Insulin receptor expression in bone. Journal of Bone and Mineral Research 1996, 11:1312-1320.
33. Thrailkill K.M., Lumpkin C.K., Bunn R.C., Kemp S.F., Fowlkes J.L. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. The American Journal of Physiology-Endocrinology and Metabolism 2005, 289:E735-E745.
34. Vogt B., Carrascosa J.M., Ermel B., Ullrich A., Häring H.U. The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochemical and Biophysical Research Communications 1991, 177:1013-1018.
35. Yamaguchi Y., Flier J.S., Yokota A., Benecke H., Backer J.M., Moller D.E. Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 1991, 129:2058-2066.